The FDA has granted orphan drug designation to onvansertib as a potential treatment for CMML, a form of blood cancer.

Columnist and caregiver Samuel Ike shares his strategy of honestly and lovingly talking to his mother when there's bad news ...

A treatment regimen using Zenbexus can reduce the risk of disease progression in people with hard-to-treat multiple myeloma, ...

An experimental treatment containing two naturally occurring pancreatic enzymes may be able to reduce the growth of cancer, a ...

When a sudden wave of exhaustion washes over columnist Gina Diamante, the thought of a multiple myeloma relapse comes rushing in, too.

An EU committee is urging that an approved myeloma drug also be cleared for use as part of a combo treatment after a ...

The first patient was dosed in an early U.S. clinical trial testing a new infusion therapy for people with ...

U.S. researchers say that using high-potency chemo during treatment with the myeloma drug Carvykti brings potential risks for ...

The experimental cancer vaccine SurVaxM may improve survival in people with newly diagnosed glioblastoma, trial results showed.

A research team is calling for new "evidence-based strategies" to reduce the risk of infections in people with myeloma ...

An immune-based vaccine created by researchers at Buffalo, New York’s Roswell Park Cancer Institute (RPCI) is now moving to its third study. The new clinical trial will evaluate whether SurVaxM — a ...

A subunit of a signaling protein may be a new therapeutic target in multiple myeloma (MM), a hematologic malignancy with high relapse rates and resulting drug resistance in patients, according to ...